EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

Citoxlab acquires Solvo Biotechnology, the leading CRO specializing in drug transporter research and Drug-Drug Interactions

With this acquisition, Citoxlab reinforces its leadership position among the top five non-clinical CROs Citoxlab Group, a leading player among non-clinical CROs, anno...
Continue Reading →
Europe

Four Medicen Paris Region members selected for the European SME Instrument program

As part of phase 2 of the EU Horizon 2020 R&D program, healthcare-focused SMEs will receive funding of €1-3M ($1.2-3.7M) for a period of 12 to 24 months Medicen P...
Continue Reading →
Europe

UK seeks investment from health and life sciences companies worldwide

The UK is the number one destination for health and life sciences foreign direct investment in Europe. That's because the fundamentals are strong: a tax structure tha...
Continue Reading →
Europe

University Hospitals system adopts Magseed marker as standard of care for localisation of impalpable breast lesions

Another top 30 cancer centre looks to standardise use of Magseed to improve patient experience Endomag, the surgical guidance company, announced today that University...
Continue Reading →
Europe

Majority of clinical trials planned in 2018 belong to oncology, says GlobalData

Cancer is one of the leading causes of morbidity and mortality across the world. Not surprisingly, oncology is going to be the top therapy area for clinical trials pl...
Continue Reading →
Europe

BCI Pharma receives €3.9M ($4.7M) in public and private funding; sets up laboratory

Funds obtained from Meusinvest, private investors and the Walloon region, coupled with new facilities at the University Hospital of Liège, helped BCI to create new bi...
Continue Reading →
Europe

Novartis’ Xolair® recommended in new global chronic urticaria guideline

A new global guideline on chronic urticaria (CU) recommends Xolair® (omalizumab), indicated as add-on therapy for the treatment of chronic spontaneous urticaria (CSU)...
Continue Reading →
Europe

Drug-producing bacteria possible with synthetic biology breakthrough

Bacteria could be programmed to efficiently produce drugs, thanks to breakthrough research into synthetic biology using engineering principles, from the University of...
Continue Reading →
Europe

Potential new approach to the treatment of multiple sclerosis

A prospective new method of treating patients with multiple sclerosis has been proposed by researchers of the Mainz University Medical Center working in cooperation w...
Continue Reading →
Europe

Poor seasonal influenza efficacy necessitates a shift away from egg-based manufacturing, says GlobalData

In February 2018, the US Centers for Disease Control and Prevention (CDC) reported 97 influenza-related pediatric deaths for the 2017–2018 influenza season, an alarmi...
Continue Reading →
Quotient